Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

John Alexander Kelly

CFO at Precision Biosciences Inc (DTIL)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $101K

Reported trades

Filed Stock Type Shares Price Value Since
Feb 19SEC DTILPrecision Biosciences Inc Sell Plan 8,149125,883 held (−6%) $3.84 $31K +50.3%
Jan 22SEC DTILPrecision Biosciences Inc Sell Plan 15,213106,448 held (−13%) $4.03 $61K +43.2%
Nov 4SEC DTILPrecision Biosciences Inc Sell Plan 1,30377,298 held (−2%) $6.49 $8K -11.1%
  • Sell

    CFO John Alexander Kelly sold $31K of DTIL at $3.84 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO John Alexander Kelly sold $61K of DTIL at $4.03 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO John Alexander Kelly sold $8K of DTIL at $6.49 — pre-scheduled 10b5-1 plan sale.